FDEV Among Ex-US Broad ETFs
End-of-day Nov 12, 2026 · 63 Ex-US broad ETFs by 5Y
Loading…
Getting the latest data.
FidelityInternationalEx-US Broad#246 of 519 by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.3% | +0.1% | +2.6% | −0.8% | +10.7% | +14.8% | +66.0% | +44.6% | +85.7% |
| Peer average | −0.6% | +1.6% | +0.4% | −4.8% | +9.5% | +11.8% | +67.1% | +47.2% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$18 of every $1,000 in FDEV is Daito
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 1878.TDaito Trust Construction | Real Estate | 1.76% | $175.90 | 238K | $4.9M |
| 2 | ROP.SWRoche AG | Healthcare | 1.73% | $172.99 | 9,891 | $4.8M |
| 3 | SHEL.LShell | Energy | 1.64% | $164.41 | 93K | $4.5M |
| 4 | H78.SIHongkong Land Hldgs | Real Estate | 1.63% | $162.54 | 541K | $4.5M |
| 5 | LI.PAKlepierre | Real Estate | 1.59% | $159.12 | 107K | $4.4M |
| 6 | AZN.LAstrazeneca (uk) | Healthcare | 1.52% | $152.18 | 23K | $4.2M |
| 7 | NOVN.SWNovartis AG (reg) | Healthcare | 1.49% | $149.09 | 26K | $4.1M |
| 8 | ASML.ASAsml | Technology | 1.38% | $138.35 | 2,452 | $3.8M |
| 9 | FSV.TOFirstservice | Real Estate | 1.37% | $136.70 | 24K | $3.8M |
| 10 | ULVR.LUnilever ORD | Consumer Defensive | 1.29% | $128.62 | 54K | $3.6M |
| 11 | TTE.PATotalenergies SE | Energy | 1.28% | $128.21 | 40K | $3.5M |
| 12 | 3659.TNexon | Technology | 1.26% | $126.12 | 183K | $3.5M |
| 13 | CNQ.TOCanadian Natl Resources | Energy | 1.17% | $117.19 | 66K | $3.2M |
| 14 | L.TOLoblaw COS | Consumer Defensive | 1.16% | $115.61 | 66K | $3.2M |
| 15 | ABI.BRAnheuser-busch Inbev / | Consumer Defensive | 1.15% | $115.41 | 38K | $3.2M |
of the $672B in 175 Ex-US broad ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 1878.T | Daito Trust Construction | 1.76% |
| 2 | ROP.SW | Roche AG | 1.73% |
| 3 | SHEL.L | Shell | 1.64% |
| 4 | H78.SI | Hongkong Land Hldgs | 1.63% |
| 5 | LI.PA | Klepierre | 1.59% |
| 6 | AZN.L | Astrazeneca (uk) | 1.52% |
| 7 | NOVN.SW | Novartis AG (reg) | 1.49% |
| 8 | ASML.AS | Asml | 1.38% |
| 9 | FSV.TO | Firstservice | 1.37% |
| 10 | ULVR.L | Unilever ORD | 1.29% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.33 |
| Jun 18, 2026 | Jun 23, 2026 | $0.38 |
| Mar 20, 2026 | Mar 24, 2026 | $0.25 |
| Dec 19, 2025 | Dec 23, 2025 | $0.26 |
| Sep 19, 2025 | Sep 23, 2025 | $0.21 |
| Jun 20, 2025 | Jun 24, 2025 | $0.29 |
| Mar 21, 2025 | Mar 25, 2025 | $0.23 |
| Dec 20, 2024 | Dec 24, 2024 | $0.14 |
| Sep 20, 2024 | Sep 24, 2024 | $0.20 |
| Jun 21, 2024 | Jun 25, 2024 | $0.27 |
| Mar 15, 2024 | Mar 20, 2024 | $0.21 |
| Dec 15, 2023 | Dec 20, 2023 | $0.12 |